Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. (DCPH) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · DCPH · as of Jun 30, 2024
Ownership Breakdown
1
Institutional Holders
▼ 178 vs Q1
$759,000
Total Inst. Value
▼ $942.89M vs Q1
86.48M
Shares Outstanding
freeFloat 53.69%
50,000
13F Shares Held
▼ 59.94M vs Q1
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
DCPH largest shareholders · institutional ownership
Q2 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
DEKABANK DEUTSCHE GIROZENTRALE pharmaceutical preparations | 50.0K | 5.72% | 5.72% | $759.00M | Aug 8, 2024 | — held |
US BANCORP \DE\ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 7, 2024 | EXIT |
NORTHERN TRUST CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 14, 2024 | EXIT |
HUNTINGTON NATIONAL BANK pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 8, 2024 | EXIT |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 14, 2024 | EXIT |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 13, 2024 | EXIT |
FRANKLIN RESOURCES INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 14, 2024 | EXIT |
PRICE T ROWE ASSOCIATES INC /MD/ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 14, 2024 | EXIT |
ROTHSCHILD INVESTMENT LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Jul 31, 2024 | EXIT |
JPMORGAN CHASE & CO pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Dec 26, 2024 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2024 vs prior quarter
Q2 2024
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares49
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
-49
0 new / 49 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
DCPH insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
1
Sell transactions
1.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Brightstar Associates LLC 10 percent owner | Apr 22, 2024 | X-InTheMoney | 48,136 | $0.01 | $481.36 | 23.11M | Form 4 ↗ |
Brightstar Associates LLC 10 percent owner | Apr 22, 2024 | X-InTheMoney | 48,136 | $0.01 | $481.36 | 0 | Form 4 ↗ |
Sherman Matthew L EVP & Chief Medical Officer | Feb 15, 2024 | Award | 17,275 | — | — | 111.4K | Form 4 ↗ |
Sherman Matthew L EVP & Chief Medical Officer | Feb 16, 2024 | Sale | 2,615 | $15.62 | $40.8K | 108.7K | Form 4 ↗ |
Sherman Matthew L EVP & Chief Medical Officer | Feb 15, 2024 | Award | 69,100 | $15.92 | $1.10M | 69.1K | Form 4 ↗ |
Kelly Thomas Patrick Chief Financial Officer | Feb 15, 2024 | Award | 17,275 | — | — | 83.4K | Form 4 ↗ |
Kelly Thomas Patrick Chief Financial Officer | Feb 16, 2024 | Sale | 3,010 | $15.62 | $47.0K | 80.3K | Form 4 ↗ |
Kelly Thomas Patrick Chief Financial Officer | Feb 15, 2024 | Award | 69,100 | $15.92 | $1.10M | 69.1K | Form 4 ↗ |
Pitman Jama SVP, Chief Development Officer | Feb 15, 2024 | Award | 10,000 | — | — | 70.3K | Form 4 ↗ |
Pitman Jama SVP, Chief Development Officer | Feb 16, 2024 | Sale | 2,267 | $15.62 | $35.4K | 68.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Deciphera Pharmaceuticals, Inc. (DCPH) is primarily owned by institutional investors, who hold approximately 0.1% of total shares outstanding. Company insiders own approximately 46.31%, while retail and public investors account for the remaining 53.63%.
The largest institutional shareholder of Deciphera Pharmaceuticals, Inc. is DEKABANK DEUTSCHE GIROZENTRALE, holding approximately 50,000 shares — equal to 5.72% of outstanding shares — as of June 30, 2024.
A total of 1 institutional investors currently hold DCPH stock, with a combined institutional value of approximately $759,000 as of the most recent 13F filing period.
Frequently asked questions
DCPH ownershipDeciphera Pharmaceuticals, Inc. (DCPH) is primarily owned by institutional investors, who hold approximately 0.1% of shares. The largest shareholder is DEKABANK DEUTSCHE GIROZENTRALE with a 5.72% stake. Company insiders hold 46.31%. Data sourced from SEC Form 13F as of June 30, 2024.